Evidence map›Paper›PMID 38013908›Full record

ArticleRSC applied polymers2023

Matrix metalloproteinase responsive hydrogel microplates for programmed killing of invasive tumour cells.

Alexander B Cook, Annalisa Palange, Michele Schlich, Elena Bellotti, Sayanti Brahmachari, Martina di Francesco, Paolo Decuzzi

Open access · diamondAbstract read
In one paragraph

Article in RSC applied polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Alexander B CookLaboratory of Nanotechnology for Precision Medicine, Istituto Italiano di Tecnologia Via Morego 16163 Genova Italy a.b.cook@tue.nl.ORCID https://orcid.org/0000-0002-5005-1039
Annalisa PalangeLaboratory of Nanotechnology for Precision Medicine, Istituto Italiano di Tecnologia Via Morego 16163 Genova Italy a.b.cook@tue.nl.
Michele SchlichLaboratory of Nanotechnology for Precision Medicine, Istituto Italiano di Tecnologia Via Morego 16163 Genova Italy a.b.cook@tue.nl.ORCID https://orcid.org/0000-0002-7214-9045
Elena BellottiLaboratory of Nanotechnology for Precision Medicine, Istituto Italiano di Tecnologia Via Morego 16163 Genova Italy a.b.cook@tue.nl.
Sayanti BrahmachariLaboratory of Nanotechnology for Precision Medicine, Istituto Italiano di Tecnologia Via Morego 16163 Genova Italy a.b.cook@tue.nl.
Martina di FrancescoLaboratory of Nanotechnology for Precision Medicine, Istituto Italiano di Tecnologia Via Morego 16163 Genova Italy a.b.cook@tue.nl.
Paolo DecuzziLaboratory of Nanotechnology for Precision Medicine, Istituto Italiano di Tecnologia Via Morego 16163 Genova Italy a.b.cook@tue.nl.
Italian Institute of Technology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interactive materials are an emerging class of systems that can offer control over response and adaptivity in polymer structures towards the meso- and macroscale. Here, we use enzyme regulated cleavage of peptide crosslinkers in polymer hydrogels to release a cytotoxic therapeutic nanoparticle with an adaptable mechanism. Hydrogel microplates were formed through polyethylene glycol/peptide photoinitiated thiol-ene chemistry in a soft-lithography process to give square plates of 20 by 20 μm with a height of 10 μm. The peptide was chosen to be degradable in the presence of matrix metalloproteinase 2/9 (MMP-2/9). The hydrogel material's mechanical properties, swelling, and protease degradation were characterised. The microfabricated hydrogels were loaded with docetaxel (DTXL) containing poly(dl-lactide-

Identifiers

PMID38013908
PMCPMC10540463
OpenAlexW4385817072

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.